Episode 24: Samsara Biocapital's Srini Akkaraju
BioVenture VoiCes with Chris Garabedian
00:00
Therapeutic focus and clinical de-risking criteria
Srini explains Samsara's therapeutic-agnostic stance and avoids areas like Alzheimer's where de-risking happens only in Phase 3.
Play episode from 01:08:01
Transcript
